A Case Of Invasive Aspergillosis in a Patient with No Identifiable Immunodeficiencies by Siddiqui, K et al.
www.ljm.org.ly    Case Report   
Libyan J Med, AOP: 071011
A Case Of Invasive Aspergillosis in a Patient 
with No Identifiable Immunodeficiencies 
 
Siddiqui K
1, Douglas M
1, Carey MP
2, Benamer HTS
1 
 
 
1 Department of Neurology, 2 Department of Neuropathology. 
Queen Elizabeth Neurosciences Centre, University Hospital Birmingham, Birmingham, UK 
 
Abstract 
Invasive fungal infections usually affect patients with immunodeficiencies and very rarely patients with no known or 
identifiable risk factors. Diagnosis could be delayed in patients without previously known immunodeficiencies due to a low 
index of suspicion, leading to a delay in treatment and a potential poor outcome. We report a case of a postpartum woman 
with no history of immuno-compromised disease who  developed left hemiparesis with evidence of invasive aspergollosis 
affecting the nervous system, and leading to fatal outcome. The patient had a mass-like lesion in the neuroimaging with soft 
tissue shadowing in the chest x-ray leading to initial diagnosis of tuberculosis. The brain biopsy showed changes consistent 
with a diagnosis of aspergillosis. The source of the aspergillus infection was not clear. Aspergillus infection should be 
considered in patients with no identifiable immunodeficiencies who have abnormal brain imaging and chest x-ray, as early 
treatment may alter the outcome. 
 
Introduction 
Central nervous system (CNS) aspergillosis is one of the 
opportunistic fungal infections that affect immuno-
compromised hosts, such as patients with; prolonged 
neutropenia, haematopoietic stem cell transplant, solid 
organ transplants particularly lung and liver, and acquired 
immunodeficiency syndrome (AIDS) [1,2]. It remains a 
rare entity in patients without known immunodeficiencies 
[1,2,3,4]. It can have a variety of presentations including 
aseptic meningitis, multiple cranial abscesses, mycotic 
aneurysms, ischaemic and haemorrhagic infarcts and 
solitary mass-like lesion [1,2,3,5]. The main source of the 
infection is usually inhalation of spores making lungs the 
primary site of infection leading to haematogenous 
dissemination to other organs. Direct extension can occur 
from the para-nasal sinuses and orbits, and direct 
inoculation at the time of surgery. Aspergillosis affecting 
the nervous system could present with altered mental 
status, seizures and focal neurological deficits, and has 
varied neuro-imaging features [4,6]. We report a patient 
with no known immunodeficiencies who presented with 
aspergillosis affecting the CNS. 
 
Case report 
A 27-year-old Pakistani woman who moved to the 
United Kingdom six months before presented with three 
days of headaches with left sided jerky movements of 
shoulder and left facial drooping. A day before admission, 
left arm and left leg weakness was noticed. Three weeks 
before the presentation the patient had uneventfully 
delivered a full term healthy baby. The general physical 
examination including the chest was recorded as normal. 
Neurological examination revealed evidence of mild left 
sided hemiparesis, with normal symmetrical reflexes and 
down-going plantars. Initial basic investigations revealed a 
normal full blood count, differential count, erythrocyte 
sedimentation rate, C- reactive protein, urea, sodium, 
potassium, liver function test, glucose and calcium. 
 
On admission a brain computed tomography (CT) 
showed evidence of hypo-density in the right frontal area 
(figure 1). Magnetic resonance imaging (MRI) brain 
showed almost homogenous circumscribed hyper-intensity 
in the right hemisphere on T2 weighted and diffusion 
weighted sequence with hypo-intense signal on T1 
weighted sequence (figure 2). Magnetic resonance 
Venogram reported as normal. At this stage it was felt 
these changes could represent an anterior circulation 
ischaemia. Patient was given aspirin and kept under 
observation. 
 
 
Figure 1  Axial CT brain showing evidence of hypodense area in 
right frontal area with minimal midline shift   
  
Forty-eight hours later the patient’s Glasgow Coma 
Score (GCS) dropped to 6, with the developing of a dense 
hemiplegia on the left side. The right pupil became fixed 
and dilated (6mm) with divergence of the right eye. The 
left pupil was of normal size (2mm) and reacting to light. 
These signs were consistent with right trans-tentorial 
herniation with compression of rostral brainstem. CT brain 
showed an increase in the size of right hemispheric hypo-
density, along with compression of midbrain and 
significant midline shift. Mannitol was given and right 
hemicraniectomy was  conducted urgently. The brain was 
oedematous on opening the skull and a partial right frontal 
lobectomy was performed, and a frontal lobe sample was 
sent for histological analysis. 
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Figure 2   A) Sagittal T1W MR showing uniform hypo-intensity   B) 
Sagittal T2W MR brain showing almost homogenous 
circumscribed hyper-intensity in right hemisphere   C) Axial 
Diffusion Weighted MR showing an area of hyper-intensity 
 
The chest x-ray was reviewed at that stage and a soft 
tissue shadowing in the right mid-zone along with calcified 
lymph nodes and mottled appearance was reported. On 
the basis of the abnormality in the chest x-ray and the 
CNS presentation it was thought that tuberculosis is the 
likely diagnosis, and after consultation with the respiratory 
team anti-tuberculous treatment was started. HIV 
screening was negative. 
 
After the procedure the patient’s condition improved 
with GCS of 11. She started communicating with family 
members and both pupils became reactive to light, but 
dense left-sided hemiparesis remained. Two days later the 
clinical status took a turn for the worse with GCS dropping 
to 3, intracranial pressure rising to 25cm H2O and then to 
35cm of H2O and became intractably high. At this stage 
the results of biopsy came back showing evidence 
consistent with aspergillosis, (figure 3) and amphotericin B 
was started. Brain CT at this stage showed extensive mass 
herniating out from the right hemicraniectomy site. 
Unfortunately she expired  24 hours later. 
 
Figure 3  A) Hematoxylin & Eosin stain shows brain with fungal 
hyphae in the centre, and associated neutrophils  B) Grocot’s 
methenamine silver staining shows septae and branching of 
hyphae 
Discussion
Aspergillus species are ubiquitous moulds found in 
organic matter [3]. More than one hundred species have 
been identified, with the majority of human illness being 
caused by Aspergillus fumigatus, Aspergillus flavus, 
Aspergillus terreus and Aspergillus niger [7]. The 
transmission of fungal spores to the human host is usually 
via inhalation, but not always. Aspergillus may cause a 
broad spectrum of disease in the human host, ranging 
from hypersensitivity reactions to direct angioinvasion. 
Aspergillus primarily affects the lungs with haematogenous 
dissemination, which can cause endophthalmitis, 
endocarditis, abscesses in the myocardium, kidney, liver, 
spleen, soft tissue, bone and CNS [1,2]. Invasive 
Aspergillosis has a significantly high mortality rate of 30-
95% [1,2,3] even higher with CNS disease, approaching 
the 100% [8]. Treatment mainly comprises of 
voriconazole, amphotericin B, itraconazole and 
capsofungin [9]. A major reason for the devastating 
prognosis in CNS aspergillosis is the delay in diagnosis and 
poor penetration of antifungal drugs into the CNS, with 
the exception of voriconazole [9]. 
  
Our patient is not known to have, and we could not 
find, an immuno-deficiency disorder, but she may have 
had undiagnosed disease such as chronic granulomatous 
disease. The rapid course of her illness made it difficult to 
ascertain  her immune status. However, the neuro-
imaging showed unusual features, as cases that have 
been described before had ring enhancement lesions, 
especially in patients with no known immunodeficiencies, 
and can be solitary or multiple lesions [4,6]. This case 
expands the spectrum of imaging features in patients with 
cerebral aspergillosis and demonstrates that a large 
circumscribed mass can be a feature of intracranial 
aspergillosis in patients with no risk factor. We presume 
that the lesion in this case resulted  from either a 
thrombosis (angioinvasion and haematogenous spread 
results in combination of arterial and venous blood flow 
impediment with resultant infarct) or a rapidly enlarging 
mass-like lesion. We hypothesize that our patient probably 
developed aspergillosis via the nasal route leading to 
pulmonary involvement first,  then spreading to the brain. 
The infection may  possibly have been acquired   
nosocomially in the maternity hospital during delivery, 
with a construction site nearby and building work going 
on, although no other cases were reported in our hospital. 
Nosocomially acquired aspergillosis has been reported 
before in immuno-suppressed patients, usually from an 
airborne source and associated with hospital construction 
or contaminated ventilation systems [10]. 
 
As the patient was not diagnosed until biopsy results 
came back four days after  admission, no anti-fungal 
drugs were given until the last 24 hours, as the clinical 
diagnosis was tuberculosis. Clinically she deteriorated so 
rapidly despite aggressive surgical treatment. A delay in 
diagnosis, a fulminant course, and poor outcome are 
common in such cases [1,2,3,8,11]. 
 
The lesson to be learned from this report is that, in 
addition to tuberculosis, aspergillosis should be considered 
in cases with unusual neuro-imaging appearances and 
abnormal CXR findings, even in patients with no known 
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immuno-deficiencies, and  treatment should be started as 
soon as possible hoping for a better outcome. 
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